Pune-based Emcure Pharmaceuticals has pulled out its proposed red herring prospectus or DRHP with securities market regulator SEBI. Emcure Pharmaceuticals on Wednesday said it has filed a draft red herring prospectus (DRHP) with the Sebi for launching an initial public offer. Pune-based Emcure Pharmaceuticals has filed draft red herring prospectus ( DRHP) with SEBI for initial public offering that includes fresh issue.
|Published (Last):||16 July 2012|
|PDF File Size:||18.80 Mb|
|ePub File Size:||3.78 Mb|
|Price:||Free* [*Free Regsitration Required]|
Foul language Slanderous Inciting hatred against a certain community Others. We have not given a thought to a pre-IPO funding round. The Thomson Reuters Trust Principles.
Thu, Dec 19 These areas include cardiology, pain and analgesics, HIV, gynecology, nephrology, anti-infective, and vitamins, minerals and nutrients. Blackstone had invested Rs crore in Emcure through convertible shares and held Ejcure in Keep me signed in. Emcure is ranked the 14th largest pharmaceutical company in India in terms of market share based on the domestic sales of pharmaceutical products, according to healthcare services information provider IMS Health India.
Interestingly, all the firms which decided not to go ahead with public floats are backed by private drjp investors. The company is engaged in developing, manufacturing and marketing a broad range of pharmaceutical products globally.
Emcure Pharmaceuticals withdraws proposed IPO
Fortis again pushes back date to complete RHT Health deal; auditor resigns. The firm is now evaluating options for an offshore listing.
Never miss a great news story!
The company commercialises its products through a combination of its own marketing and distribution infrastructure. For the nine months period ended December For the nine months ended December 31,Emcure’s revenue from operations was Rs 1, crore with net profit at Rs Link Intime India Private Limited is a registrar to the issue.
BSCPL is an infrastructure development company which operates in road, irrigation, real estate and hydro power projects.
Emure will alert our moderators to take action Name Reason for reporting: Here’s how the world is celebrating Christmas.
Emcure Pharmaceuticals files DRHP for IPO – The Economic Times
Choose your reason below and click on the Report button. Emcure Pharmaceuticals withdraws proposed IPO. Warren Buffett has this piece of advice for youngsters and it’s not stocks. This is the second exit by Blackstone from its India portfolio. Pune-based Emcure Pharmaceuticals has pulled out its proposed initial public offer IPO which was to raise around Rs crore besides giving part exit to Blackstone in its maiden investment in India.
Leave Your Comment s. Fri, Dec 20 Will be displayed Will not be displayed Will be displayed. Blackstone has invested Rs crore in Emcure through convertible shares and currently holds a Emcure was the first private equity investment by a Blackstone-managed fund in India.
Crude oil prices to direct sugar prices in By Jasleen Kaur Batra.
Emcure Pharmaceuticals files IPO papers with SEBI –
Secondary transactions set the ground for appropriate valuations as there is no information arbitrage unlike in a primary transaction. Infibeam calls off pact to acquire Snapdeal unit Unicommerce. Emcure Pharmaceuticals acquires Canadian company and its marketing arm Marcan. My Saved Articles Sign in Sign up. Private equity major Blackstone has started the process of exiting its maiden investment in India, Emcure Pharmaceuticals. From Berlin to Washington: These areas include cardiology, pain and analgesics, HIV, gynecology, nephrology, anti-infective, and vitamins, minerals and nutrients.